Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.14% | 28.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.16% | 36.01% | |||
| Operating Income | -21.16% | -36.01% | |||
| Income Before Tax | -21.09% | -34.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.09% | -34.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.09% | -34.23% | |||
| EBIT | -21.16% | -36.01% | |||
| EBITDA | -21.44% | -36.69% | |||
| EPS Basic | 42.66% | -25.04% | |||
| Normalized Basic EPS | 42.65% | -28.30% | |||
| EPS Diluted | 42.66% | -25.04% | |||
| Normalized Diluted EPS | 42.65% | -28.30% | |||
| Average Basic Shares Outstanding | 111.16% | 7.35% | |||
| Average Diluted Shares Outstanding | 111.16% | 7.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||